F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 22 filers reported holding F-STAR THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $227,000 | +198.7% | 36,291 | +70.5% | 0.02% | +233.3% |
| Q1 2022 | $76,000 | -30.9% | 21,291 | -2.7% | 0.01% | -25.0% |
| Q4 2021 | $110,000 | -36.4% | 21,879 | -7.3% | 0.01% | -42.9% |
| Q3 2021 | $173,000 | -13.1% | 23,604 | +2.1% | 0.01% | -6.7% |
| Q2 2021 | $199,000 | -20.4% | 23,129 | 0.0% | 0.02% | -25.0% |
| Q1 2021 | $250,000 | +9.6% | 23,129 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $228,000 | – | 23,129 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 574,996 | $2,944,000 | 1.06% |
| AlphaCentric Advisors LLC | 165,000 | $845,000 | 0.87% |
| DAFNA Capital Management LLC | 576,881 | $2,954,000 | 0.80% |
| Knott David M Jr | 235,945 | $1,208,000 | 0.51% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3,070,000 | 0.34% |
| S. MUOIO & CO. LLC | 40,000 | $205,000 | 0.27% |
| Murchinson Ltd. | 162,624 | $833,000 | 0.24% |
| Connolly Sarah T. | 53,001 | $271,000 | 0.20% |
| BCK CAPITAL MANAGEMENT LP | 52,000 | $266,000 | 0.19% |
| Diametric Capital, LP | 44,449 | $228,000 | 0.12% |